IP Library Granted Patent US 12,274,557
Granted Patent B2
US 12,274,557 · App. 17/162,105 · Granted Apr 15, 2025

Methods and systems for evaluating the integrity of a uterine cavity

Inventors: Akos Toth (Cupertino, CA); Robin Bek (Campbell, CA); Dominique Filloux (Redwood City, CA)
Assignee: MINERVA SURGICAL, INC.
A61B5/4325A61B5/4836A61B18/042A61B18/1485A61M13/003A61M31/00A61B2017/4216A61B2018/00214A61B2018/00559A61B2018/00577A61B2018/00821A61B2018/147A61B2505/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,274,557
App. No.
17/162,105
Granted
Apr 15, 2025
Kind
B2
Abstract

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO 2 ) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.

Claims (42)

1. A system for characterizing a patient's uterus, the system comprising:

a probe having an inflation lumen and a uterine flow lumen;

an inflatable member adapted for releasably sealing off the patient's cervical canal, the inflatable member fluidly coupled with the inflation lumen;

a source of inflation fluid fluidly coupled with the inflation lumen;

a source of a uterine flow fluid fluidly coupled with the uterine flow lumen;

a sensor fluidly coupled with the uterine flow lumen, the sensor adapted to provide a sensor output relating to flow of the uterine flow fluid; and

a controller that is operably coupled with the sensor and with the source of the uterine flow fluid, the controller adapted to control the flow of the uterine flow fluid in order to ascertain whether the patient's uterus has been compromised;

wherein the controller is adapted to determine that the patient's uterus is intact when the flow of the uterine flow fluid drops to near zero within a time period.

2. The system of claim 1 , wherein the uterine flow lumen terminates at a distal end that is distal of the inflatable member.

3. The system of claim 1 , wherein the controller is adapted to determine that the patient's uterus is not intact when the flow of the uterine flow fluid does not drop to near zero within the time period.

4. The system of claim 1 , wherein the time period is 30 seconds or less.

5. The system of claim 1 , wherein the time period is between 5 and 30 seconds.

6. The system of claim 1 , further comprising:

an expandable dielectric member adapted to be inserted into the patient's uterus; and

a dielectric member inflation lumen fluidly coupled with an interior of the expandable dielectric member.

7. The system of claim 1 , wherein the probe is adapted to be inserted through the patient's cervical canal into the patient's uterus.

8. A system for characterizing a patient's uterus, the system comprising:

a probe adapted to be inserted through a patient's cervical canal and into the patient's uterus, the probe including a distal working end;

an inflatable member disposed on the probe, the inflatable member adapted for releasably sealing off the patient's cervical canal when inflated;

a source of inflation fluid fluidly coupled with the inflatable member;

a source of a uterine flow fluid fluidly coupled with the distal working end;

a sensor fluidly coupled with the source of uterine flow fluid, the sensor adapted to provide a sensor output relating to flow of the uterine flow fluid; and

a controller that is operably coupled with the sensor and with the source of the uterine flow fluid, the controller adapted to control a flow of the uterine flow fluid from the source of the uterine flow fluid in order to ascertain a health of the patient's uterus;

wherein the controller is adapted to determine that the patient's uterus is healthy when the flow of the uterine flow fluid drops to near zero within a time period.

9. The system of claim 8 , further comprising:

an expandable dielectric member adapted to be inserted into the patient's uterus; and

a source of dielectric member inflation fluid fluidly coupled with an interior of the expandable dielectric member.

10. The system of claim 8 , wherein the controller is adapted to determine that the patient's uterus is unhealthy when the flow of the uterine flow fluid does not drop to near zero within the time period.

11. The system of claim 8 , wherein the time period is 30 seconds or less.

12. The system of claim 8 , wherein the time period is at least 5 seconds.

13. A system for characterizing a patient's uterus, the system comprising:

a probe adapted to be inserted through a patient's cervical canal and into the patient's uterus, the probe including a distal working end;

an inflatable member disposed on the probe, the inflatable member adapted for releasably sealing off the patient's cervical canal when inflated;

a source of an inflation fluid fluidly coupled with the inflatable member;

a source of a uterine flow fluid fluidly coupled with the distal working end;

an expandable dielectric member adapted to be inserted into the patient's uterus;

a source of a dielectric member inflation fluid fluidly coupled with an interior of the expandable dielectric member;

a sensor fluidly coupled with the source of the uterine flow fluid, the sensor adapted to provide a sensor output relating to a change in flow of the uterine flow fluid; and

a controller operably coupled with the sensor and with the source of the uterine flow fluid, the controller adapted to control the flow of the uterine flow fluid from the source of the uterine flow fluid in order to ascertain a health of the patient's uterus.

14. The system of claim 13 , wherein the controller is adapted to determine that the patient's uterus is healthy when the flow of the uterine flow fluid drops to near zero within a time period.

15. The system of claim 14 , wherein the controller is adapted to determine that the patient's uterus is unhealthy when the flow of the uterine flow fluid does not drop to near zero within the time period.

16. The system of claim 14 , wherein the time period is between 5 seconds and 30 seconds.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0186 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2021
From: TOTH, AKOS; BEK, ROBIN; FILLOUX, DOMINIQUE
To: MINERVA SURGICAL, INC.
Reel/Frame 057299/0165 →
Continuity (5)
Continuation 16023464 · Jun 29, 2018
Continuation 15488395 · Apr 14, 2017
Division 13361089 · Jan 30, 2012
Provisional Application 61439788 · Feb 4, 2011
Related Publication 20210345941A1 · Nov 11, 2021
References Cited (66)
US 3948259A · Bolduc et al. · 1976 [cited by applicant]
US 4611602A · Bolduc · 1986 [cited by applicant]
US 4611604A · Botvidsson et al. · 1986 [cited by applicant]
US 4650462A · Desatnick et al. · 1987 [cited by applicant]
US 4979948A · Geddes et al. · 1990 [cited by applicant]
US 5147353A · Everett · 1992 [cited by applicant]
US 5191883A · Lennox et al. · 1993 [cited by applicant]
US 5437629A · Goldrath · 1995 [cited by applicant]
US 5460628A · Neuwirth et al. · 1995 [cited by applicant]
US 5549546A · Schneider et al. · 1996 [cited by applicant]
US 5653726A · Kieturakis · 1997 [cited by applicant]
US 5769880A · Truckai et al. · 1998 [cited by applicant]
US 5891134A · Goble et al. · 1999 [cited by applicant]
US 5925038A · Panescu et al. · 1999 [cited by applicant]
US 5954715A · Harrington et al. · 1999 [cited by applicant]
US 6041260A · Stern et al. · 2000 [cited by applicant]
US 6159160A · Hsei et al. · 2000 [cited by applicant]
US 6296639B1 · Truckai et al. · 2001 [cited by applicant]
US 6309384B1 · Harrington et al. · 2001 [cited by applicant]
US 6626827B1 · Felix et al. · 2003 [cited by applicant]
US 6663626B2 · Truckai et al. · 2003 [cited by applicant]
US 6736811B2 · Panescu et al. · 2004 [cited by applicant]
US 6813520B2 · Truckai et al. · 2004 [cited by applicant]
US 6872183B2 · Sampson et al. · 2005 [cited by applicant]
US 7073504B2 · Callister et al. · 2006 [cited by applicant]
US 7220259B2 · Harrington et al. · 2007 [cited by applicant]
US 7320325B2 · Duchon et al. · 2008 [cited by applicant]
US 7371231B2 · Rioux et al. · 2008 [cited by applicant]
US 7731712B2 · Sampson et al. · 2010 [cited by applicant]
US 8343078B2 · Toth · 2013 [cited by applicant]
US 9289257B2 · Toth et al. · 2016 [cited by applicant]
US 9655557B2 · Toth et al. · 2017 [cited by applicant]
US 10028696B2 · Toth et al. · 2018 [cited by applicant]
US 10932712B2 · Toth et al. · 2021 [cited by applicant]
US 20040215099A1 · Sampson et al. · 2004 [cited by applicant]
US 20050143728A1 · Sampson et al. · 2005 [cited by applicant]
US 20050240211A1 · Sporri et al. · 2005 [cited by applicant]
US 20070088344A1 · Schechter et al. · 2007 [cited by applicant]
US 20080097425A1 · Truckai · 2008 [cited by applicant]
US 20080167664A1 · Payne et al. · 2008 [cited by applicant]
US 20080178889A1 · Tal · 2008 [cited by applicant]
US 20080243054A1 · Mollstam et al. · 2008 [cited by applicant]
US 20090054892A1 · Rioux et al. · 2009 [cited by applicant]
US 20090149846A1 · Hoey et al. · 2009 [cited by applicant]
US 20100100091A1 · Truckai · 2010 [cited by applicant]
US 20100100094A1 · Truckai · 2010 [cited by applicant]
US 20100106152A1 · Truckai · 2010 [cited by examiner]
US 20100137857A1 · Shroff et al. · 2010 [cited by applicant]
US 20100198214A1 · Layton, Jr. et al. · 2010 [cited by applicant]
US 20110087109A1 · Swann · 2011 [cited by applicant]
US 20110112432A1 · Toth · 2011 [cited by applicant]
WO WO2006021880A2 · 2006 [cited by applicant]
WO WO2011060191A1 · 2011 [cited by applicant]
WO WO2012106474A2 · 2012 [cited by applicant]
European Search Report dated Aug. 21, 2017 for European Patent Application No. EP 12742391.1. [cited by applicant]
International search report and written opinion dated Sep. 28, 2012 for PCT/US2012/023548. [cited by applicant]
Notice of Allowance dated Jan. 18, 2017 for U.S. Appl. No. 13/361,089. [cited by applicant]
“Office action dated Mar. 6, 2014 for U.S. Appl. No. 13/361,089.”. [cited by applicant]
“Office action dated Apr. 23, 2015 for U.S. Appl. No. 13/361,089.”. [cited by applicant]
Office action dated Jun. 9, 2020 for U.S. Appl. No. 16/023,464. [cited by applicant]
“Office action dated Aug. 13, 2015 for U.S. Appl. No. 13/361,089.”. [cited by applicant]
Office action dated Aug. 22, 2016 for U.S. Appl. No. 13/361,089. [cited by applicant]
Office Action dated Sep. 14, 2017 for U.S. Appl. No. 15/488,395. [cited by applicant]
“Office action dated Sep. 25, 2014 for U.S. Appl. No. 13/361,089.”. [cited by applicant]
Third party observations dated Sep. 6, 2013 for EP Application No. 10830743.0. [cited by applicant]
U.S. Appl. No. 15/488,395 Notice of Allowance dated Mar. 29, 2018. [cited by applicant]